Director, Drug Product Process Development - Biologics

Job Description

Biologics, Cell and Gene Therapy is a rapidly growing part of Vertex Pharmaceuticals where research, development, and clinical manufacturing are highly integrated together at our new R&D site in Boston Seaport.

Vertex is seeking a highly skilled technical leader to join our Process Development / Engineering team to lead the development and manufacturing of biologics drug products for our growing pipeline. The Vertex Process Development team offers a dynamic, fast-paced, and highly collaborative environment with a tremendous impact on our programs and for our patients. Our team focuses on bringing together the best process design, scale‑up and cutting‑edge manufacturing technologies to enable the successful implementation of Biologics, Cell and Genetic therapeutics.

The successful candidate will lead the development and manufacturing of biologics drug products. The responsibilities include formulation development, primary container development, fill‑finish process development, technology transfer of manufacturing processes to CDMOs, and process validation to support our clinical pipeline toward commercialization. This is a highly cross‑functional role that will work closely with drug substance development, analytical development, device development and supply chain management in CMC teams to drive technical and strategic decision‑making.

• Lead phase‑appropriate strategies for drug product development, process transfer, scale‑up and process characterization to support commercial readiness.
• Set‑up and oversee external capabilities for develop ability assessment and formulation screening for high‑concentration biologics, ADCs and other biologics modalities.
• Define and develop robust fill‑finish manufacturing processes for liquid and lyophilized drug products in vials, pre‑filled syringes and other novel primary packaging.
• Oversee drug product technology transfer, process development and GMP manufacturing operations at CDMOs.
• Define and develop clinical dose preparation and administration strategies for drug products for multiple indications. Collaborate with clinical and supply chain teams to prepare clinical study documentation.
• Collaborate with the device development team to develop combination product presentations such as pre‑filled syringes, autoinjectors and advance delivery technologies.
• Define and implement drug substance and drug product stability and shelf‑life assessment approaches.
• Develop and manage project timelines, resource allocation, and budget for drug product programs.
• Manage deviations and OOT/OOS investigations at the CDMOs in collaboration with Quality, External Manufacturing and Regulatory team.
• Define and implement control strategies, validation protocols, and process characterization studies in accordance with Quality by Design (QbD) principles.
• Author and review regulatory submissions: IND/IMPD, briefing books and BLA.
• Serve as a subject matter expert in regulatory agency interactions, audits, and inspections.
• Identify and implement innovative technologies and best practices to improve process robustness, efficiency, and compliance.
• Potential in the future to build and manage a team of scientists and engineers to deliver high‑quality, scalable, and compliant drug product processes from early development through commercialization.
• Expected travel: 10-20% (domestic and international).

• PhD in Chemical Engineering, Biochemical Engineering, Pharmaceutical Sciences or related discipline with commensurate years of education and experience.
• Minimum of 11 years of experience in drug product development and manufacturing. MS with 14+ years of relevant experience may be considered.

• Expertise in formulation development of recombinant proteins including antibodies, ADCs, and fusion proteins.
• Expertise in developing stable, high concentration liquid formulation and dosage forms for biologics and applying cutting‑edge technologies to develop stable drug products.
• Deep knowledge in developing aseptic fill‑finish manufacturing process for biologics drug products in vials, pre‑filled syringe and…